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Abstract
This manuscript describes a novel strategy to improve HIV DNA vaccine design. Employing a new information theory based
bioinformatic algorithm, we identify a set of nucleotide motifs which are common in the coding region of HIV, but are
under-represented in genes that are highly expressed in the human genome. We hypothesize that these motifs contribute
to the poor protein expression of gag, pol, and env genes from the c-DNAs of HIV clinical isolates. Using this approach and
beginning with a codon optimized consensus gag gene, we recode the nucleotide sequence so as to remove these motifs
without modifying the amino acid sequence. Transfecting the recoded DNA sequence into a human kidney cell line results
in doubling the gag protein expression level compared to the codon optimized version. We then turn both sequences into
DNA vaccines and compare induced antibody response in a murine model. Our sequence, which has the motifs removed,
induces a five-fold increase in gag antibody response compared to the codon optimized vaccine.
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Introduction
In the effort to create a vaccine for human immunodeficiency
virus type 1 (HIV-1), poor immune response to the HIV proteins is
a fundamental problem. For a DNA vaccine, the immune
response is correlated with protein expression levels, so an increase
in expression of these proteins could alleviate a significant road
block to the construction of a viable DNA vaccine.[1,2]
Transcription of the HIV DNA copy is an inefficient process that
is aided by the addition of an HIV protein (TAT). In addition the
large mRNAs from HIV have inherent RNA processing problems
and are not efficiently exported from the nucleus in the absence of
a helper protein (REV). These m-RNA synthesis and transport
problems are presumably due to a set of RNA sequences or
structures encoded in HIV DNA and RNAs.[3,4] We hypothesize
that identifying and removing these signals, which cause the poor
synthesis and nuclear confinement of HIV RNA, should
significantly increase expression levels of these proteins and
improve the immune response.
The genome of HIV-1 contains nine open reading frames
(ORFs), all of which are expressed from a single promoter through
alternative splicing. The splice forms for the six ORFs Gag, Pol,
Env, Vpu, Vif, and Vpr, along with the full length mRNA, contain
Rev response elements (RREs) encoded in their RNA. In the
absence of the Rev protein, these six ORFs are poorly expressed.
The remaining three ORFs, Tat, Rev, and Nef, are expressed
efficiently independently of the Rev protein.[3]
The mRNAs which contain RREs likely also contain an as yet
unidentified signal or set of signals which prevents normal
expression.[4] A primary cause of the poor expression of these
ORFs is nuclear confinement.[3] The genome of HIV-1 has an
anomalous nucleotide distribution as compared with the set of
known coding genes in the human genome. Only 314 of the
approximately 25000 genes in the human genome have a higher
percentage of adenine (A) than the average clinical isolate of HIV-
1. Similar A content can be found in other retrotranscribing
viruses (e.g. LINE elements, lentiviruses, spumaviruses); this
suggests that retroviruses undergo different selection pressures
than ones directing the evolution of the human genome. In the
early 90’s, the Pavlakis lab showed experimentally that synony-
mous changes to the Gag ORF, which decrease the A content,
significantly increase expression of Gag in human cells.[4] Codon-
optimized strains, which are widely used in present experiments
and vaccine trials, can increase the protein expression level of Gag
transfected into human cells between 500 and 1000 fold.[1,2]
However, the substantial increase in expression due to codon
optimization can, at best, indirectly address the problem of poor
synthesis and nuclear isolation. We identify multiple nucleotide
motifs from a systematic comparison of the HIV-1 genome and the
human genome, which we conjecture to play a causative role in
poor synthesis and nuclear confinement.
In this study, the short motif, AGG, is found to have the
maximal differential representation between the coding genes in
the human genome and the HIV-1 genome. This identification
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finding method called the Robins-Krasnitz algorithm, described
previously[5].The algorithm identifies dozens of motifs that exhibit
substantial differences in representation between the HIV-1 genome
and the human coding genes. The study presented here focuses on a
single motif in order to isolate its contribution to expression level in a
controlled experiment. A codon-optimized version of HIV-1
consensus gag is modified, making synonymous changes to reduce
the number of occurrences of AGG. Two plasmids are constructed,
one with the original codon-optimized (CO) sequence of gag (AD-
gag) and the other with the motif-optimized (MO) sequence with
AGG significantly reduced (RK-gag). The (DNA) constructs are
transfected into a human epithelial cellline (293 cells)and expression
of Gag is shown to be 70% higher for the MO sequence. The two
sequences of gag are also tested as DNA vaccines in a murine model
for differential immune responses between the two constructs. The
mice withthe MOversionofthevaccine have a 4.5-foldgreateranti-
Gag antibody response after 4 weeks. With a DNA boost at four
weeks and a second readout of anti-Gag antibody titers measured at
six weeks, the gap continues to widen between the MO and CO
vaccines to 6-fold.
Results
Finding the signal and recoding Gag
The Robins-Krasnitz algorithm finds short nucleotide motifs in
coding regions of the human genome that are independent of
amino acid order and codon usage.[5] Codon usage is defined as
the distribution of synonymous codons present in a given gene.
The result of the Robins-Krasnitz algorithm is a set of exact
nucleotide motifs of length 2–7 bases which are under and over
represented in the coding regions of the human genome. The
frequency of these motifs in the HIV genome can then be assessed.
See Methods for details.
Beginning with the set of the 100 most under- and over-
represented motifs in the human genome, our study attempts to
identify the motif with the largest density difference between the
HIV genome and the human genome, after accounting for A
content. The motifs are restricted to the set of human genes with A
content within 1% of the average HIV A content. The ratios of the
densities in the HIV genome are then divided by densities in the
human coding regions. If the human density is greater than that of
HIV, the quantity is replaced by its reciprocal. We predict that the
motif with the largest ratio of densities is responsible for nuclear
isolation of HIV mRNAs.
The triplet AGG, which is significantly under represented in the
coding region of the human genome, is found with a high
frequency in HIV when the nucleotide bias of HIV is taken into
consideration. We hypothesize that recoding the ORFs of HIV by
reducing the frequency of the motif AGG will increase protein
expression.
For this initial study, our experimental tests focused on the Gag
gene. The codon-optimized sequence of gag, referred to as AD-
gag, is recoded by systematically removing all AGGs such that the
amino acid sequence is not modified and very rare codons are not
introduced. The result is the motif optimized RK-gag. Both the
AD-gag and RK-gag sequences are found in the supplementary
materials.
Testing expression
First, we determine whether our RK-gag has increased
expression as compared to the codon optimized version, AD-
gag. Since our version of Gag is undoing part of the codon
optimization present in the AD-gag sequence, the protein
expression levels should be expected to decrease unless the motif
AGG significantly inhibits mRNA synthesis or processing or
transport. To compare expression levels, human 293 cells were
transfected in vitro with one of the two different versions of Gag (see
methods for details). Gag protein expression was measured in the
extracts of transfected cells by a quantitative P24 ELISA. RK-gag
was 70% higher than the codon optimized AD-gag, with a p-value
,0.00001 calculated by a permutation test (see Figure 1).
Humoral immune response
To test the effect of the almost two-fold gain in expression on the
immune response, we created DNA vaccines from each of the
sequences. These DNA vaccines were injected into the hind leg
muscle of Balb/C mice. The mice were given a booster shot after
four weeks. Anti-Gag antibody titers were measured by anti-P24
ELISA at the four week and six week time points (see Methods for
details). The results are found in Figure 2. The 70% increase in the
expression of the GAG protein in vitro translated into more than a
five-fold difference in humoral immune response in a mouse model.
Two weeks post-boost, mice were sacrificed and splenocytes
were prepared for measuring Gag-specific cell-mediated immune
(CMI) responses by an IFN-c ELISpot assay. Although the
difference between these two groups was not statistically
significant, there was a trend for RK-gag immunized mice to
have stronger CMI responses to both Gag-specific CD4 and CD8
peptides tested (data not shown).
Discussion
Recoding the Gag gene in order to reduce the occurrences of a
single triplet, AGG, substantially improves immune response to an
HIV DNA vaccine in a mouse model. This short sequence motif
occurs less frequently in the human coding sequence than in the
mouse coding sequence byabout twenty percent, soitispossiblethat
these results would be even more dramatic in humans. A set of
additional steps would be required to move in the direction of a
clinically viable vaccine. These include a recoding of the ENV ORF
and a test of its ability to induce an improved immune response.
Testing these concepts in primates would be a useful step. The goal
of this study was to provide convincing evidence that recoding the
HIV ORFs can improve HIV protein expression and the immune
response compared to the present codon optimization schemes. It
likely that including the other motifs identified by the Robins-
Krasnitz algorithm in a systematic way has the potential to improve
upon the large gains displayed in this study.
Figure 1. Gag expression in transiently transfected 293 cells.
Figure 1 presents the results from four independent transfection
experiments. The results are expressed as the mean P24 value (ng/ml,
6SD) of triplicates. The two different gag sequences are the codon
optimized version (AD) and the motif optimized version (RK) that we
created. Our (RK) version of the Gag gene has approximately two-fold
higher expression than the codon optimized version.
doi:10.1371/journal.pone.0003214.g001
Recoded HIV Vaccine
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sequence has been selected to express poorly in primate cells, only
increasing its levels with the aid of additional proteins that
recognize nucleic acid sequences in the genome. Several other
retroviruses and retrotransposons have similar sequence complex-
ities. This may reflect an optimal way to regulate these viruses and
enhance the viral titers over an extended length of infection. In
any event it is becoming clear that nucleotide sequence motifs, in
addition to the choice of codons, can have dramatic impacts upon
gene expression, RNA processing and transport in a cell.
Methods
Robins-Krasnitz algorithm
The first step in the algorithm is the creation of a background
sequence to compare with the human genome. This background is
a completely randomized version of the coding sequences from the
human genome subject to the constraints of amino acid order and
codon usage in each gene. We design a Monte Carlo program that
randomly permutes the codons for each amino acid within each
gene. Figure 3 is an illustrative example.
The shuffling procedure described above yields a set of
randomized sequences. From these sequences, we need to extract
a probability distribution. As long as the number of occurrences of
each motif found in the total set of sequences is reasonably large,
we can form a probability distribution, estimating the probability
of a given motif by its fraction in the set of all motifs.
After the shuffling procedure we can define two distributions,
the real distribution found from the actual sequence and the
Maximal Entropy Distribution (MED) which we use as the
surrogate for the background. We now need a method for
choosing under and over-represented motifs. The standard we
used is from information theory. The motif that contributes the
most bits of information to the difference between the real
distribution and the MED is the first motif we chose. Using
information theory has the nice feature of putting all results in the
same units, number of bits. This allows us to compare motifs of
different lengths and motifs that are either over or under-
represented. The formula we employ to compute the motif
contributing the most bits of information between the two
distributions is the Kullback-Leibler distance or the Relative
Entropy. We compute the Relative Entropy contribution for each
motif and pick out the one with the largest value.
Once we have found the most under- or over-represented motif
in the sequence, we have to pick out the motif which is the next
most under- or over-represented. However, we cannot simply take
the motif which has the next largest Relative Entropy. This is
because the motifs are overlapping, so under or over representa-
tion of a given motif affects the distribution of all the other motifs.
The example of CpG illustrates this point. In the human genome,
the dinucleotide motif CG will have the largest Relative Entropy.
However, all eight trimers which contain CG fall within the top 50
highest Relative Entropy motifs. This is simply an artifact of the
selection against CG. We are required to first remove the
contribution of CG from the MED before recalculating the
Relative Entropy to find the next motif. If we call the motif w,w e
rescale all motifs that contain w by the same amount so that the
rescaled MED had the same distribution for w as the real
distribution. This forces the Relative Entropy of w to zero and, at
the same time, removes the contribution of w from all other motifs.
We can readily show that this choice of rescaling monotonically
decreases the overall Relative Entropy between the distributions.
The procedure is iterated, so that we remove the contribution of
one motif at a time from the Relative Entropy through rescaling of
the MED. Then, we choose the next motif. We continue to iterate
the procedure, and find additional motifs, until the motif with the
largest remaining Relative Entropy is not statistically significant, as
determined by comparing shuffled genomes.
Experimental protocols
HIV-1 subtype B gag consensus sequence was obtained from the
Los Alamos HIV database (www.hiv.lanl.gov). The complete
sequence of parental consensus gag was codon optimized to reflect
the codon characteristics of eukaryotic expression systems (AD-
gag) and assembled in house using overlapping PCR.[4,6] RK-gag
was synthesized by BlueHeron Biotechnology (www.blueheronbio.
com). Both constructs have an identical ‘‘Kozak signal’’ located
immediately upstream of the initial ATG and were cloned into
NotI and XbaI cloning sites of pVAX1 (Invitrogen).
Plasmid DNAs were prepared by GenElute Endotoxin-free
plasmid purification system (Sigma). For valuation of gag
expression in vitro, multiple batches of plasmid DNA were prepared
to ensure the reproducibility of each of the independent
transfection experiments. Briefly, 0.5 and 1 mg of DNA were
transfected into 293 cells using the Lipofectamine reagent in a 24-
well plate format according to the manufacturer’s specification
Figure 2. Immunogenicity of Gag DNA vaccines in mouse. The
two different versions of Gag were made into DNA vaccines and
injected into Balb/C mice with 25 mg/dose, then boosted at four weeks.
Anti-Gag antibody levels were measured by ELISA at the four week and
six week time points. The results are expressed as the geometric mean
antibody titers (6SD) of each group. RK-Gag, induced an immune
response that was five times larger than the codon optimized version at
four weeks, which increased to a factor of 6 difference after six weeks.
doi:10.1371/journal.pone.0003214.g002
Figure 3. Example of shuffling procedure. The procedure to get
the maximal entropy distribution (MED) involves a set of randomized
iterations. The triplets of nucleotides coding for each amino acid are
permuted randomly among themselves. This is an illustrative example
of a mock short protein with eight amino acids. The shuffling procedure
randomly permutes L1,L 2,L 3, and L4 and separately permutes H1,H 2,
and H3. Each iteration produces a new sequence. For this example,
there are 12 different combinations for the leucines and three
combinations for the histidines resulting in 36 unique sequences. They
are weighted in the shuffling procedure so that the MED is attained in
the limit of a large number of iterations.
doi:10.1371/journal.pone.0003214.g003
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72 hours post transfection. Gag expression was measured by a
commercial ELISA kit that detects and quantifies P24 in
supernatant (PerkinElmer).
For assessing immunogenicity in mouse model, DNA was eluted
into saline at the concentration of 0.5 mg/ml. Independent batches
of DNA were prepared for immunizations. Six to eight week old
female BALB/c mice (Charles River Laboratories) were housed
and treated at the Laboratory Animal Research Center of The
Rockefeller University in accordance with Institutional Animal
Care and Use Committee guidelines. Groups of mice (4 to 5 per
group) were immunized with a 25 mg of plasmid DNA vaccine in
50 ml of saline at week 0 and week 4. Serum samples were
collected from individual mice at week 4 (4 weeks post first
vaccination) and week 6 (2 weeks post second vaccination). Direct
ELISA was used to measure serum anti-Gag antibody titers from
immunized mice. Briefly, 96-well plates coated with 0.25 mg
recombinant P24 protein overnight were blocked for 2 hours with
PBS-T containing 5% dry milk and 0.5% BSA. Individual mouse
serum samples were added in serial dilutions and incubated for
2 hours. The plates were washed five times with PBS-T and
incubated for one hour with AKP-conjugated rat anti-mouse
secondary antibodies. The plates were then washed six times with
AMPAK washing solution, developed with AMPAK kit (DAKO
Corporation). The plates were read on an ELISA reader at
490 nm. The end-point antibody titers were calculated as the
reciprocal dilution of the last dilution that was at least 2-fold higher
than normal mice sera controls and yields an absorbance of .0.1.
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